D G Meuleman Selected Research

Org 42675

9/2003

Antithrombotic properties of a direct thrombin inhibitor with a prolonged half-life and AT-mediated factor Xa inhibitory activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D G Meuleman Research Topics

Disease

4	Thrombosis (Thrombus) 01/2008 - 10/2000
1	Atherosclerosis 01/2001
1	Body Weight (Weight, Body) 01/2001
1	Osteoporosis 01/2001
1	Thrombocytopenia (Thrombopenia) 10/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2000

Drug/Important Bio-Agent (IBA)

2	Thrombin FDA Link 01/2008 - 10/2000
2	Heparin (Liquaemin)FDA LinkGeneric 09/2003 - 10/2000
2	Pharmaceutical PreparationsIBA 01/2001 - 10/2000
1	Thromboplastin (Tissue Factor)IBA 12/2003
1	Org 42675IBA 09/2003
1	Fondaparinux (Arixtra)FDA Link 09/2003
1	argatroban (MPQA)FDA Link 09/2003
1	tiboloneIBA 01/2001
1	CholesterolIBA 01/2001
1	ferric chlorideIBA 10/2000
1	AntibodiesIBA 10/2000
1	idraparinuxIBA 10/2000
1	Org 36764IBA 10/2000
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2000
1	BuffersIBA 10/2000

Therapy/Procedure

1	Stents 10/2000